source
- Key AUA 2026 abstracts to watch: immunotherapy for NMIBC and radioligand therapy for mHSPCThe American Urological Association 2026 meeting will feature several highly anticipated abstracts. Experts say immunotherapy for non‑muscle‑invasive bladder cancer is a major focus, reflecting gr…
- Experts clarify differences between glioblastoma and diffuse midline glioma under 2021 WHO classificationIn the opening episode of their series, Dr. Shonka and Dr. Chong introduce a discussion about two distinct diseases that both carry the name glioma. They explain that glioblastoma and diffuse midl…